Milford have owned Neuren Pharmaceuticals since October 2007.In the past they supported capital raisings in June 2020 and September 2021 and announced a substantial shareholder position in December 2021 with a 5.2% shareholding.
It does appear that Milford have now taken some profit off the table and reduced their current stock holdings of 6.2% back to the December 2021 substantial shareholder position of 5.2%.
Kens
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.03 |
Change
-0.510(4.07%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $1.383M | 115.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 127 | $12.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.05 | 163 | 2 |
View Market Depth
| Last trade - 10.34am 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |